Cargando…

The efficacy of Chinese patent medicine intervention on blood glucose and lipid in prediabetes: A meta-analysis

OBJECTIVE: The purpose of this study was to analyze the efficacy and safety of Chinese patent medicine in the treatment of blood glucose, blood lipid and insulin resistance in prediabetic patients through a meta-analysis of clinical trials. METHODS: Randomized controlled trials of Chinese patent med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Kaile, Tian, Chuanxi, Guo, Can, Li, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761722/ https://www.ncbi.nlm.nih.gov/pubmed/36544847 http://dx.doi.org/10.1016/j.heliyon.2022.e12112

Ejemplares similares

Efficacy and safety of traditional Chinese medicines combined with conventional Western medicines in the treatment of type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials
por: Ma, Kaile, et al.
Publicado: (2023)

Treatment options of traditional Chinese patent medicines for dyslipidemia in patients with prediabetes: A systematic review and network meta-analysis
por: Jiang, Li, et al.
Publicado: (2022)

The Effects of Postprandial Resistance Exercise on Blood Glucose and Lipids in Prediabetic, Beta-Thalassemia Major Patients
por: Georgakouli, Kalliopi, et al.
Publicado: (2020)

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis
por: Duan, Nai-fan, et al.
Publicado: (2021)

Comparative efficacy and safety of Chinese patent medicines of acute ischemic stroke: A network meta-analysis
por: Xu, Yuan, et al.
Publicado: (2023)

Verification of the Efficacy and Safety of Qi-Replenishing Chinese Medicine in Treating Prediabetes: A Meta-Analysis and Literature Review
por: Xia, Shujie, et al.
Publicado: (2020)

Chinese patent medicine for osteoporosis: a systematic review and meta-analysis
por: Jia, Yan, et al.
Publicado: (2022)

Tracking Blood Glucose and Predicting Prediabetes in Chinese Children and Adolescents: A Prospective Twin Study
por: Wang, Guoying, et al.
Publicado: (2011)

Comparative efficacy and safety of traditional Chinese patent medicine for endometriosis: A Bayesian network meta-analysis protocol
por: Dong, Shuangqian, et al.
Publicado: (2019)

Efficacy and safety of Chinese patent medicine injection for COVID-19: A protocol for systematic review and meta-analysis
por: Lu, Meiqi, et al.
Publicado: (2020)

Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis
por: Xu, He, et al.
Publicado: (2020)

Therapeutic efficacy of Chinese patent medicine containing pyrite for fractures: A protocol for systematic review and meta-analysis
por: Choi, Su Hyeon, et al.
Publicado: (2022)

Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Lihui, et al.
Publicado: (2023)

Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta− analysis
por: Su, Wenquan, et al.
Publicado: (2023)

Network meta-analysis of Chinese patent medicine adjuvant treatment of poststroke depression
por: Yu, Ying, et al.
Publicado: (2020)

Interrater Reliability of Chinese Medicine Diagnosis in People with Prediabetes
por: Grant, Suzanne J., et al.
Publicado: (2013)

Challenges and patenting strategies for Chinese herbal medicine
por: Wang, Xinsheng, et al.
Publicado: (2010)

A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes
por: Luo, Yingying, et al.
Publicado: (2022)

Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2020)

Comparative efficacy and safety of traditional Chinese patent medicine for endometriosis: A Bayesian network meta-analysis protocol: Erratum
Publicado: (2019)

Efficacy and safety of traditional Chinese patent medicine on carotid artery atherosclerosis in adults: A network meta-analysis protocol
por: Sun, Huiqing, et al.
Publicado: (2021)

Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy: A protocol for Bayesian network meta-analysis
por: Liu, Shilin, et al.
Publicado: (2022)

DNA based identification of medicinal materials in Chinese patent medicines
por: Chen, Rong, et al.
Publicado: (2012)

Effects of lifestyle interventions on glucose regulation and diabetes risk in adults with impaired glucose tolerance or prediabetes: a meta-analysis
por: Jiang, Qiang, et al.
Publicado: (2022)

Traditional Chinese Patent Medicine for Primary Hypertension: A Bayesian Network Meta-Analysis
por: Chen, Zhe, et al.
Publicado: (2020)

Associations of Insulin Levels and Insulin Resistance With Urine Glucose Excretion Independent of Blood Glucose in Chinese Adults With Prediabetes and Newly Diagnosed Diabetes
por: Chen, Juan, et al.
Publicado: (2018)

Comparison of efficacy and safety of Chinese patent medicine in the treatment of postmenopausal osteoporosis: A protocol for systematic review and network meta-analysis
por: An, Hongqiang, et al.
Publicado: (2020)

Assessment of the efficacy of Chinese patent medicine on treating pain caused by prostate cancer: A protocol for systematic review and meta analysis
por: Gong, Xiaoyong, et al.
Publicado: (2019)

An Efficacy and Feasibility Analysis of Chinese Patent Medicine Combined With Letrozole in the Treatment of Women With Ovulation Disorders: A Network Meta-Analysis
por: Zhu, Jing-Yan, et al.
Publicado: (2021)

A Network Meta-Analysis of the Clinical Efficacy and Safety of Commonly Used Chinese Patent Medicines in the Auxiliary Treatment of Poststroke Depression
por: Yu, Ying, et al.
Publicado: (2022)

Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Chuihua, et al.
Publicado: (2021)

Efficacy and safety of Chinese patent medicine compound preparation combined with routine treatment in vitiligo: A Bayesian network meta-analysis
por: Wang, Jianfeng, et al.
Publicado: (2023)

Expert Consensus on the Treatment of Hypertension with Chinese Patent Medicines
por: Wang, Li Ying, et al.
Publicado: (2013)

Effects of vitamin D supplementation on the regulation of blood lipid levels in prediabetic subjects: A meta-analysis
por: Yang, Yixue, et al.
Publicado: (2023)

Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes
por: Sevilla-Gonzalez, Magdalena del Rocio, et al.
Publicado: (2022)

Effectiveness of Chinese patent medicine in the treatment of influenza: A protocol for systematic review and meta-analysis
por: Liu, Kang, et al.
Publicado: (2021)

Clinical efficacy and safety of traditional Chinese patent medicine for hyperthyroid heart disease: study protocol for a systematic review and meta-analysis
por: Wang, Qing, et al.
Publicado: (2018)

Efficacy and Safety of “Three Chinese Patent Medicines and Three TCM Prescriptions” for COVID-19: A Systematic Review and Network Meta-Analysis
por: Zhang, Shuo, et al.
Publicado: (2022)

Efficacy and Safety of the Chinese Patent Medicine Yuquan Pill on Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis
por: Peng, Sihan, et al.
Publicado: (2021)

Efficacy and Safety of Chinese Patent Medicine for the Prevention and Treatment of Radiotherapy and Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis
por: Xie, Yufei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_68ipec3i4tqf1mj9p0lcr962k9